325 related articles for article (PubMed ID: 27405985)
1. A critical view on cardiovascular risk in systemic sclerosis.
Psarras A; Soulaidopoulos S; Garyfallos A; Kitas G; Dimitroulas T
Rheumatol Int; 2017 Jan; 37(1):85-95. PubMed ID: 27405985
[TBL] [Abstract][Full Text] [Related]
2. Atherosclerosis and macrovascular involvement in systemic sclerosis: myth or reality.
Nussinovitch U; Shoenfeld Y
Autoimmun Rev; 2011 Mar; 10(5):259-66. PubMed ID: 20863903
[TBL] [Abstract][Full Text] [Related]
3. Is atherosclerosis accelerated in systemic sclerosis? Novel insights.
Soriano A; Afeltra A; Shoenfeld Y
Curr Opin Rheumatol; 2014 Nov; 26(6):653-7. PubMed ID: 25198242
[TBL] [Abstract][Full Text] [Related]
4. Systemic sclerosis and risk of cardiovascular disease: A PRISMA-compliant systemic review and meta-analysis of cohort studies.
Cen X; Feng S; Wei S; Yan L; Sun L
Medicine (Baltimore); 2020 Nov; 99(47):e23009. PubMed ID: 33217802
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular disease in systemic sclerosis--an emerging association?
Ngian GS; Sahhar J; Wicks IP; Van Doornum S
Arthritis Res Ther; 2011 Aug; 13(4):237. PubMed ID: 21888685
[TBL] [Abstract][Full Text] [Related]
6. Myocardial fibrosis detected by magnetic resonance imaging, elevated U-CRP and higher mRSS are predictors of cardiovascular complications in systemic sclerosis (SSc) patients.
Rodríguez-Reyna TS; Rosales-Uvera SG; Kimura-Hayama E; Hernández-Reyes P; Mercado-Velázquez P; Benavides-Suárez SA; Esquinca-González A; Núñez-Álvarez CA
Semin Arthritis Rheum; 2019 Oct; 49(2):273-278. PubMed ID: 30853116
[TBL] [Abstract][Full Text] [Related]
7. Macrovascular disease and atherosclerosis in SSc.
Hettema ME; Bootsma H; Kallenberg CG
Rheumatology (Oxford); 2008 May; 47(5):578-83. PubMed ID: 18321944
[TBL] [Abstract][Full Text] [Related]
8. [Cardiac complications in rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis].
Gawrysiak W; Skrypnik K; Suliburska J; Skrypnik D; Bogdański P
Przegl Lek; 2017; 74(4):179-82. PubMed ID: 29696959
[TBL] [Abstract][Full Text] [Related]
9. [Systemic sclerosis and macrovascular involvement: Status of the issue in 2019].
Bertolino J; Scafi M; Benyamine A; Aissi K; Boufi M; Schleinitz N; Sarlon G; Rossi P; Granel B
J Med Vasc; 2019 Dec; 44(6):400-421. PubMed ID: 31761307
[TBL] [Abstract][Full Text] [Related]
10. Assessment of myocardial fibrosis and microvascular damage in systemic sclerosis by magnetic resonance imaging and coronary angiotomography.
Rodríguez-Reyna TS; Morelos-Guzman M; Hernández-Reyes P; Montero-Duarte K; Martínez-Reyes C; Reyes-Utrera C; Vazquez-La Madrid J; Morales-Blanhir J; Núñez-Álvarez C; Cabiedes-Contreras J
Rheumatology (Oxford); 2015 Apr; 54(4):647-54. PubMed ID: 25239881
[TBL] [Abstract][Full Text] [Related]
11. [Prevalence of macrovascular arterial involvement of the 4 limbs in systemic sclerosis: About a case series of 14 patients].
Watelet B; Jeancolas J; Lanéelle D; Bienvenu B; Le Hello C
Rev Med Interne; 2017 Jul; 38(7):430-435. PubMed ID: 28602440
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular magnetic resonance in systemic sclerosis: "Pearls and pitfalls".
Mavrogeni SI; Schwitter J; Gargani L; Pepe A; Monti L; Allanore Y; Matucci-Cerinic M
Semin Arthritis Rheum; 2017 Aug; 47(1):79-85. PubMed ID: 28522072
[TBL] [Abstract][Full Text] [Related]
13. Primary myocardial involvement in systemic sclerosis: evidence for a microvascular origin.
Allanore Y; Meune C
Clin Exp Rheumatol; 2010; 28(5 Suppl 62):S48-53. PubMed ID: 21050545
[TBL] [Abstract][Full Text] [Related]
14. Effect of a single IV administration of L-propionylcarnitine on myocardial microcirculation assessed by coronary flow velocity reserve measurement in patients with systemic sclerosis: a pilot study.
Montisci R; Ruscazio M; Lai S; Vacca A; Cauli A; Passiu G; Montisci M; Meloni L; Mathieu A; Iliceto S
Clin Ther; 2007 Jan; 29(1):163-71. PubMed ID: 17379056
[TBL] [Abstract][Full Text] [Related]
15. Atherosclerotic cardiovascular disease in hospitalized patients with systemic sclerosis: higher mortality than patients with lupus and rheumatoid arthritis.
Dave AJ; Fiorentino D; Lingala B; Krishnan E; Chung L
Arthritis Care Res (Hoboken); 2014 Feb; 66(2):323-7. PubMed ID: 24022876
[TBL] [Abstract][Full Text] [Related]
16. The 15% rule in scleroderma: the frequency of severe organ complications in systemic sclerosis. A systematic review.
Muangchan C; ; Baron M; Pope J
J Rheumatol; 2013 Sep; 40(9):1545-56. PubMed ID: 23858045
[TBL] [Abstract][Full Text] [Related]
17. Circulating endothelial progenitor cells in systemic sclerosis: relation to impaired angiogenesis and cardiovascular manifestations.
Nevskaya T; Bykovskaia S; Lyssuk E; Shakhov I; Zaprjagaeva M; Mach E; Ananieva L; Guseva N; Nassonov E
Clin Exp Rheumatol; 2008; 26(3):421-9. PubMed ID: 18578963
[TBL] [Abstract][Full Text] [Related]
18. Ischemic arterial events and atherosclerosis in patients with systemic sclerosis: a population-based case-control study.
Nordin A; Jensen-Urstad K; Björnådal L; Pettersson S; Larsson A; Svenungsson E
Arthritis Res Ther; 2013 Aug; 15(4):R87. PubMed ID: 23945149
[TBL] [Abstract][Full Text] [Related]
19. The burden and measurement of cardiovascular disease in SSc.
Mok MY; Lau CS
Nat Rev Rheumatol; 2010 Jul; 6(7):430-4. PubMed ID: 20517296
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular disease in systemic sclerosis.
Cannarile F; Valentini V; Mirabelli G; Alunno A; Terenzi R; Luccioli F; Gerli R; Bartoloni E
Ann Transl Med; 2015 Jan; 3(1):8. PubMed ID: 25705640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
